Pfizer Expected To Ask FDA To Authorize COVID-19 Booster for 16-17-Year-olds

Pfizer and BioNTech are set to ask the Food and Drug Administration to give authorization to its coronavirus booster shot for 16- and 17-year-olds in the coming days. The Washington Post reports that the FDA regulators are expected to sign off on the authorization quickly,…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button